105 related articles for article (PubMed ID: 11358433)
1. Desensitization of chemokine receptor CCR5 in dendritic cells at the early stage of differentiation by activation of formyl peptide receptors.
Le Y; Wetzel MA; Shen W; Gong W; Rogers TJ; Henderson EE; Wang JM
Clin Immunol; 2001 Jun; 99(3):365-72. PubMed ID: 11358433
[TBL] [Abstract][Full Text] [Related]
2. A new insight into the role of "old" chemotactic peptide receptors FPR and FPRL1: down-regulation of chemokine receptors CCR5 and CXCR4.
Le Y; Shen W; Li B; Gong W; Dunlop NM; Wang JM
Forum (Genova); 1999; 9(4):299-314. PubMed ID: 10611407
[TBL] [Abstract][Full Text] [Related]
3. The synthetic peptide WKYMVm attenuates the function of the chemokine receptors CCR5 and CXCR4 through activation of formyl peptide receptor-like 1.
Li BQ; Wetzel MA; Mikovits JA; Henderson EE; Rogers TJ; Gong W; Le Y; Ruscetti FW; Wang JM
Blood; 2001 May; 97(10):2941-7. PubMed ID: 11342415
[TBL] [Abstract][Full Text] [Related]
4. Activation of the chemotactic peptide receptor FPRL1 in monocytes phosphorylates the chemokine receptor CCR5 and attenuates cell responses to selected chemokines.
Shen W; Proost P; Li B; Gong W; Le Y; Sargeant R; Murphy PM; Van Damme J; Wang JM
Biochem Biophys Res Commun; 2000 May; 272(1):276-83. PubMed ID: 10872839
[TBL] [Abstract][Full Text] [Related]
5. Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation.
Le Y; Gong W; Li B; Dunlop NM; Shen W; Su SB; Ye RD; Wang JM
J Immunol; 1999 Dec; 163(12):6777-84. PubMed ID: 10586077
[TBL] [Abstract][Full Text] [Related]
6. Human dendritic cells express functional formyl peptide receptor-like-2 (FPRL2) throughout maturation.
Yang D; Chen Q; Gertz B; He R; Phulsuksombati M; Ye RD; Oppenheim JJ
J Leukoc Biol; 2002 Sep; 72(3):598-607. PubMed ID: 12223529
[TBL] [Abstract][Full Text] [Related]
7. IFN-gamma and IL-12 differentially regulate CC-chemokine secretion and CCR5 expression in human T lymphocytes.
Losana G; Bovolenta C; Rigamonti L; Borghi I; Altare F; Jouanguy E; Forni G; Casanova JL; Sherry B; Mengozzi M; Trinchieri G; Poli G; Gerosa F; Novelli F
J Leukoc Biol; 2002 Oct; 72(4):735-42. PubMed ID: 12377943
[TBL] [Abstract][Full Text] [Related]
8. The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptide receptor but not the formyl peptide receptor like 1.
Stenfeldt AL; Karlsson J; Wennerås C; Bylund J; Fu H; Dahlgren C
Biochem Pharmacol; 2007 Oct; 74(7):1050-6. PubMed ID: 17692291
[TBL] [Abstract][Full Text] [Related]
9. T21/DP107, A synthetic leucine zipper-like domain of the HIV-1 envelope gp41, attracts and activates human phagocytes by using G-protein-coupled formyl peptide receptors.
Su SB; Gao Jl; Gong Wh; Dunlop NM; Murphy PM; Oppenheim JJ; Wang JM
J Immunol; 1999 May; 162(10):5924-30. PubMed ID: 10229829
[TBL] [Abstract][Full Text] [Related]
10. Human cytomegalovirus inhibits the migration of immature dendritic cells by down-regulating cell-surface CCR1 and CCR5.
Varani S; Frascaroli G; Homman-Loudiyi M; Feld S; Landini MP; Söderberg-Nauclér C
J Leukoc Biol; 2005 Feb; 77(2):219-28. PubMed ID: 15522919
[TBL] [Abstract][Full Text] [Related]
11. Selective inactivation of CCR5 and decreased infectivity of R5 HIV-1 strains mediated by opioid-induced heterologous desensitization.
Szabo I; Wetzel MA; Zhang N; Steele AD; Kaminsky DE; Chen C; Liu-Chen LY; Bednar F; Henderson EE; Howard OM; Oppenheim JJ; Rogers TJ
J Leukoc Biol; 2003 Dec; 74(6):1074-82. PubMed ID: 12972507
[TBL] [Abstract][Full Text] [Related]
12. A synthetic peptide derived from human immunodeficiency virus type 1 gp120 downregulates the expression and function of chemokine receptors CCR5 and CXCR4 in monocytes by activating the 7-transmembrane G-protein-coupled receptor FPRL1/LXA4R.
Deng X; Ueda H; Su SB; Gong W; Dunlop NM; Gao JL; Murphy PM; Wang JM
Blood; 1999 Aug; 94(4):1165-73. PubMed ID: 10438703
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of the chemokine receptor CCR5 by activation of chemotactic formyl peptide receptor in human monocytes.
Shen W; Li B; Wetzel MA; Rogers TJ; Henderson EE; Su SB; Gong W; Le Y; Sargeant R; Dimitrov DS; Oppenheim JJ; Wang JM
Blood; 2000 Oct; 96(8):2887-94. PubMed ID: 11023526
[TBL] [Abstract][Full Text] [Related]
14. Functional and physical interactions between formyl-peptide-receptors and scavenger receptor MARCO and their involvement in amyloid beta 1-42-induced signal transduction in glial cells.
Brandenburg LO; Konrad M; Wruck CJ; Koch T; Lucius R; Pufe T
J Neurochem; 2010 May; 113(3):749-60. PubMed ID: 20141570
[TBL] [Abstract][Full Text] [Related]
15. I-TAC/CXCL11 is a natural antagonist for CCR5.
Petkovic V; Moghini C; Paoletti S; Uguccioni M; Gerber B
J Leukoc Biol; 2004 Sep; 76(3):701-8. PubMed ID: 15178708
[TBL] [Abstract][Full Text] [Related]
16. IL-12 plays a pivotal role in LFA-1-mediated T cell adhesiveness by up-regulation of CCR5 expression.
Mukai T; Iwasaki M; Gao P; Tomura M; Yashiro-Ohtani Y; Ono S; Murai M; Matsushima K; Kurimoto M; Kogo M; Matsuya T; Fujiwara H; Hamaoka T
J Leukoc Biol; 2001 Sep; 70(3):422-30. PubMed ID: 11527992
[TBL] [Abstract][Full Text] [Related]
17. TAK-652 inhibits CCR5-mediated human immunodeficiency virus type 1 infection in vitro and has favorable pharmacokinetics in humans.
Baba M; Takashima K; Miyake H; Kanzaki N; Teshima K; Wang X; Shiraishi M; Iizawa Y
Antimicrob Agents Chemother; 2005 Nov; 49(11):4584-91. PubMed ID: 16251299
[TBL] [Abstract][Full Text] [Related]
18. House dust mite allergen activates human eosinophils via formyl peptide receptor and formyl peptide receptor-like 1.
Svensson L; Redvall E; Björn C; Karlsson J; Bergin AM; Rabiet MJ; Dahlgren C; Wennerås C
Eur J Immunol; 2007 Jul; 37(7):1966-77. PubMed ID: 17559171
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of CCR5-mediated infection by diverse R5 and R5X4 HIV and SIV isolates using novel small molecule inhibitors of CCR5: effects of viral diversity, target cell and receptor density.
Willey S; Peters PJ; Sullivan WM; Dorr P; Perros M; Clapham PR
Antiviral Res; 2005 Nov; 68(2):96-108. PubMed ID: 16157392
[TBL] [Abstract][Full Text] [Related]
20. CCR5 chemokine receptor mediates recruitment of MHC class II-positive Langerhans cells in the mouse corneal epithelium.
Yamagami S; Hamrah P; Miyamoto K; Miyazaki D; Dekaris I; Dawson T; Lu B; Gerard C; Dana MR
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1201-7. PubMed ID: 15790880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]